Intrinsic value of BioNexus Gene Lab Corp. (BGLC)

Live fair value data for BioNexus Gene Lab Corp. (BGLC) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Upside: +38.0%

Margin of Safety: +27.5%

Current Price: $320.00

Valuation: Undervalued

Confidence: 8.0/10

Visual Bar

Market Price $320.00Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Intrinsic Value checker

Enter any ticker to open its intrinsic value analysis page.

Is BioNexus Gene Lab Corp. (BGLC) undervalued or overvalued?

Based on the current model output, BioNexus Gene Lab Corp. appears to be undervalued with a upside of 38.00%.

Fair value vs market price — BioNexus Gene Lab Corp. (BGLC)

Unlock premium access to view the live fair value comparison against current market price for BGLC.

Frequently Asked Questions - BGLC

How is BGLC intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for BGLC.

Is BGLC undervalued or overvalued right now?

BGLC is currently shown as undervalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for BGLC: open their intrinsic value pages.

Explore Other Stocks